Actavis plc today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex (Buprenorphine 2 mg and 8 mg sublingual tablets).
from The Medical News http://ift.tt/1AXmnve
from The Medical News http://ift.tt/1AXmnve
No comments:
Post a Comment